Milin Peng
About
In The Last Decade
Milin Peng
21 papers receiving 291 citations
Peers
Comparison fields: 5 of 64
- Epidemiology 126
- Surgery 76
- Molecular Biology 58
- Pulmonary and Respiratory Medicine 54
- Cancer Research 52
Countries citing papers authored by Milin Peng
This map shows the geographic impact of Milin Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milin Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milin Peng more than expected).
Fields of papers citing papers by Milin Peng
This network shows the impact of papers produced by Milin Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milin Peng. The network helps show where Milin Peng may publish in the future.
Co-authorship network of co-authors of Milin Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Milin Peng. A scholar is included among the top collaborators of Milin Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milin Peng. Milin Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 29 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 22 | |
| 9 | 7 | |
| 10 | 21 | |
| 11 | 2 | |
| 12 | 24 | |
| 13 | 60 | |
| 14 | 30 | |
| 15 | 4 | |
| 16 | 10 | |
| 17 | 33 | |
| 18 | 17 | |
| 19 | 13 | |
| 20 | [Dynamic changes in PD-1, TLR3, and TLR4 surface expression on peripheral blood mononuclear cells in chronic hepatitis C patients undergoing peg-IFNalpha-2a plus ribavirin combination therapy]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.